Latest News
Redwire Shares Surge on Record $498M Backlog, Defense Orders in Focus
Redwire shares surged 10% on Monday after reporting a record backlog of $498.1 million, including a $1.8 billion Andromeda contract, and reaffirming its 2026 revenue outlook.
SoFi Technologies to Acquire PrimaryBid, Expanding Retail IPO Access
SoFi Technologies is set to acquire most of PrimaryBid, aiming to expand retail investor access to IPOs. The deal sent SOFI stock up 1.7%.
IonQ Shares Jump 16% After SkyWater Vote Advances Quantum Chip Deal
IonQ shares surged 16% after SkyWater Technology shareholders approved the $1.8B acquisition, bringing semiconductor manufacturing in-house for the quantum computing firm.
Tesla Shares Climb Despite China Sales Dip on Musk's China Trip Hopes
Tesla shares rose 2.8% despite a 9.66% drop in April China retail sales, as exports surged and Musk's potential China trip with Trump boosted sentiment.
IREN Shares Slide on $2B Convertible Note Sale Amid AI Pivot
IREN Limited shares dropped after the company launched a $2 billion convertible note sale to finance its AI infrastructure buildout, including a major Nvidia cloud deal.
Nokia Stock Climbs on AI Cloud Growth, Investor Optimism Returns
Nokia shares surged 4.1% on Monday, driven by a 49% jump in AI and cloud sales and 1 billion euros in orders, though analysts caution on valuation.
Coterra Energy Delisted After Devon Merger, Combined Entity Targets $1B in Synergies
Coterra Energy shares have stopped trading on the NYSE after Devon Energy completed its all-stock acquisition. Former Coterra holders received 0.70 Devon shares per Coterra share, and the merged firm now trades under DVN.
Nebius Shares Surge Ahead of Q1 Earnings as $18 Billion Capex Plan Faces Test
Nebius Group shares surged to $190.98, approaching record highs, as investors await Q1 earnings. The AI cloud firm's $18 billion capex target and major deals with Meta and Microsoft are key.
Pfizer's Recovery Play: Can New Drugs Offset Patent Cliff?
Pfizer stock gains on Q1 beat and steady outlook, but investors weigh patent cliff risks against new oncology and GLP-1 drug prospects.
BigBear.ai Director Sells Shares as Defense AI Backlog Grows
BigBear.ai director Dorothy Hayes sold 15,000 shares for $61,575 on May 8, following a report of a $281.9 million backlog and reaffirmed 2026 revenue guidance.
